annual CFO:
$572.84M+$413.58M(+259.69%)Summary
- As of today (September 13, 2025), BMRN annual cash flow from operations is $572.84 million, with the most recent change of +$413.58 million (+259.69%) on December 31, 2024.
- During the last 3 years, BMRN annual CFO has risen by +$268.31 million (+88.10%).
- BMRN annual CFO is now at all-time high.
Performance
BMRN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$185.27M+$10.88M(+6.24%)Summary
- As of today (September 13, 2025), BMRN quarterly cash flow from operations is $185.27 million, with the most recent change of +$10.88 million (+6.24%) on June 30, 2025.
- Over the past year, BMRN quarterly CFO has increased by +$66.51 million (+56.00%).
- BMRN quarterly CFO is now -16.35% below its all-time high of $221.48 million, reached on September 30, 2024.
Performance
BMRN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$766.77M+$66.51M(+9.50%)Summary
- As of today (September 13, 2025), BMRN TTM cash flow from operations is $766.77 million, with the most recent change of +$66.51 million (+9.50%) on June 30, 2025.
- Over the past year, BMRN TTM CFO has increased by +$437.91 million (+133.16%).
- BMRN TTM CFO is now at all-time high.
Performance
BMRN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BMRN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +259.7% | +56.0% | +133.2% |
| 3 y3 years | +88.1% | +229.5% | +544.2% |
| 5 y5 years | +1086.9% | +568.0% | +447.6% |
BMRN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +259.7% | -16.4% | +350.6% | at high | +544.2% |
| 5 y | 5-year | at high | +1086.9% | -16.4% | +350.6% | at high | +798.2% |
| alltime | all time | at high | +351.4% | -16.4% | +208.1% | at high | +359.2% |
BMRN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $185.27M(+6.2%) | $766.77M(+9.5%) |
| Mar 2025 | - | $174.39M(-6.1%) | $700.26M(+22.2%) |
| Dec 2024 | $572.84M(+259.7%) | $185.63M(-16.2%) | $572.84M(+38.1%) |
| Sep 2024 | - | $221.48M(+86.5%) | $414.70M(+26.1%) |
| Jun 2024 | - | $118.76M(+152.8%) | $328.86M(+17.4%) |
| Mar 2024 | - | $46.97M(+70.9%) | $280.16M(+75.9%) |
| Dec 2023 | $159.26M(-9.5%) | $27.48M(-79.7%) | $159.26M(+14.9%) |
| Sep 2023 | - | $135.65M(+93.6%) | $138.56M(-14.1%) |
| Jun 2023 | - | $70.06M(-194.8%) | $161.24M(+9.4%) |
| Mar 2023 | - | -$73.93M(-1189.5%) | $147.40M(-16.2%) |
| Dec 2022 | $175.90M(-42.2%) | $6.79M(-95.7%) | $175.90M(-2.4%) |
| Sep 2022 | - | $158.32M(+181.6%) | $180.30M(+51.5%) |
| Jun 2022 | - | $56.23M(-223.8%) | $119.03M(-18.2%) |
| Mar 2022 | - | -$45.43M(-506.4%) | $145.59M(-52.2%) |
| Dec 2021 | $304.54M(+256.7%) | $11.18M(-88.5%) | $304.54M(+8.8%) |
| Sep 2021 | - | $97.06M(+17.2%) | $279.97M(+4.0%) |
| Jun 2021 | - | $82.78M(-27.1%) | $269.12M(+25.7%) |
| Mar 2021 | - | $113.51M(-948.1%) | $214.07M(+150.8%) |
| Dec 2020 | $85.36M(+76.9%) | -$13.38M(-115.5%) | $85.36M(-45.3%) |
| Sep 2020 | - | $86.21M(+210.8%) | $156.09M(+11.5%) |
| Jun 2020 | - | $27.74M(-282.6%) | $140.01M(+59.2%) |
| Mar 2020 | - | -$15.19M(-126.5%) | $87.94M(+82.2%) |
| Dec 2019 | $48.26M(+138.8%) | $57.34M(-18.2%) | $48.26M(+19.8%) |
| Sep 2019 | - | $70.13M(-388.1%) | $40.29M(+132.0%) |
| Jun 2019 | - | -$24.34M(-55.6%) | $17.37M(+121.3%) |
| Mar 2019 | - | -$54.87M(-211.1%) | $7.85M(-61.2%) |
| Dec 2018 | $20.21M(-330.8%) | $49.37M(+4.6%) | $20.21M(-238.9%) |
| Sep 2018 | - | $47.20M(-239.4%) | -$14.55M(-38.0%) |
| Jun 2018 | - | -$33.86M(-20.4%) | -$23.46M(-180.4%) |
| Mar 2018 | - | -$42.51M(-390.9%) | $29.18M(-433.2%) |
| Dec 2017 | -$8.76M(-96.2%) | $14.61M(-61.8%) | -$8.76M(-62.9%) |
| Sep 2017 | - | $38.29M(+103.9%) | -$23.58M(-67.4%) |
| Jun 2017 | - | $18.78M(-123.3%) | -$72.24M(-47.2%) |
| Mar 2017 | - | -$80.44M(>+9900.0%) | -$136.83M(-39.9%) |
| Dec 2016 | -$227.84M(+2.7%) | -$210.00K(-98.0%) | -$227.84M(-23.0%) |
| Sep 2016 | - | -$10.37M(-77.4%) | -$295.83M(+2.6%) |
| Jun 2016 | - | -$45.80M(-73.3%) | -$288.31M(+12.9%) |
| Mar 2016 | - | -$171.45M(+151.4%) | -$255.33M(+15.1%) |
| Dec 2015 | -$221.85M(+198.9%) | -$68.20M(+2293.0%) | -$221.85M(+23.0%) |
| Sep 2015 | - | -$2.85M(-77.8%) | -$180.43M(-3.3%) |
| Jun 2015 | - | -$12.83M(-90.7%) | -$186.61M(+0.7%) |
| Mar 2015 | - | -$137.97M(+415.3%) | -$185.31M(+149.7%) |
| Dec 2014 | -$74.21M(+24.4%) | -$26.78M(+196.5%) | -$74.21M(+26.4%) |
| Sep 2014 | - | -$9.03M(-21.7%) | -$58.73M(-0.8%) |
| Jun 2014 | - | -$11.53M(-57.1%) | -$59.19M(+8.7%) |
| Mar 2014 | - | -$26.87M(+137.9%) | -$54.48M(-8.6%) |
| Dec 2013 | -$59.63M(-438.7%) | -$11.30M(+19.0%) | -$59.63M(+64.0%) |
| Sep 2013 | - | -$9.49M(+39.2%) | -$36.35M(+187.5%) |
| Jun 2013 | - | -$6.82M(-78.7%) | -$12.65M(+74.5%) |
| Mar 2013 | - | -$32.03M(-367.2%) | -$7.25M(-141.2%) |
| Dec 2012 | $17.61M(-6.1%) | $11.99M(-15.7%) | $17.61M(+223.2%) |
| Sep 2012 | - | $14.21M(-1101.0%) | $5.45M(+5634.7%) |
| Jun 2012 | - | -$1.42M(-80.2%) | $95.00K(-99.4%) |
| Mar 2012 | - | -$7.17M(+3997.7%) | $15.08M(-19.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $18.75M(+0.0%) | -$175.00K(-102.0%) | $18.75M(+496.1%) |
| Sep 2011 | - | $8.86M(-34.7%) | $3.15M(-5.9%) |
| Jun 2011 | - | $13.57M(-487.7%) | $3.34M(-72.1%) |
| Mar 2011 | - | -$3.50M(-77.8%) | $12.00M(-36.0%) |
| Dec 2010 | $18.75M(-78.6%) | -$15.78M(-274.3%) | $18.75M(-65.3%) |
| Sep 2010 | - | $9.06M(-59.2%) | $53.99M(-27.0%) |
| Jun 2010 | - | $22.22M(+583.7%) | $74.01M(+4.3%) |
| Mar 2010 | - | $3.25M(-83.3%) | $70.96M(-19.1%) |
| Dec 2009 | $87.73M(-1056.2%) | $19.47M(-33.0%) | $87.73M(+21.5%) |
| Sep 2009 | - | $29.07M(+51.6%) | $72.23M(+60.4%) |
| Jun 2009 | - | $19.17M(-4.2%) | $45.04M(+36.2%) |
| Mar 2009 | - | $20.02M(+404.7%) | $33.06M(-460.4%) |
| Dec 2008 | -$9.18M(-73.4%) | $3.97M(+110.5%) | -$9.18M(-17.2%) |
| Sep 2008 | - | $1.89M(-73.8%) | -$11.08M(-51.2%) |
| Jun 2008 | - | $7.19M(-132.4%) | -$22.70M(-38.0%) |
| Mar 2008 | - | -$22.22M(-1176.6%) | -$36.59M(+6.1%) |
| Dec 2007 | -$34.49M(-31.1%) | $2.06M(-121.2%) | -$34.49M(-27.1%) |
| Sep 2007 | - | -$9.73M(+45.3%) | -$47.29M(-5.6%) |
| Jun 2007 | - | -$6.70M(-66.7%) | -$50.10M(-1.4%) |
| Mar 2007 | - | -$20.13M(+87.5%) | -$50.84M(+1.5%) |
| Dec 2006 | -$50.09M(-20.1%) | -$10.73M(-14.5%) | -$50.09M(-13.7%) |
| Sep 2006 | - | -$12.55M(+68.7%) | -$58.03M(-14.1%) |
| Jun 2006 | - | -$7.44M(-61.6%) | -$67.57M(+6.1%) |
| Mar 2006 | - | -$19.38M(+3.8%) | -$63.65M(+1.6%) |
| Dec 2005 | -$62.68M(-3.8%) | -$18.67M(-15.4%) | -$62.68M(+17.2%) |
| Sep 2005 | - | -$22.08M(+526.6%) | -$53.48M(+3.9%) |
| Jun 2005 | - | -$3.52M(-80.9%) | -$51.47M(-25.9%) |
| Mar 2005 | - | -$18.40M(+94.4%) | -$69.51M(+6.7%) |
| Dec 2004 | -$65.14M(-12.9%) | -$9.46M(-52.9%) | -$65.14M(-26.5%) |
| Sep 2004 | - | -$20.08M(-6.9%) | -$88.66M(-2.8%) |
| Jun 2004 | - | -$21.56M(+53.7%) | -$91.22M(+18.4%) |
| Mar 2004 | - | -$14.03M(-57.5%) | -$77.03M(+3.0%) |
| Dec 2003 | -$74.80M(+39.6%) | -$32.99M(+45.7%) | -$74.80M(-1.6%) |
| Sep 2003 | - | -$22.64M(+206.9%) | -$76.01M(+27.7%) |
| Jun 2003 | - | -$7.38M(-37.5%) | -$59.52M(+4.3%) |
| Mar 2003 | - | -$11.80M(-65.5%) | -$57.06M(+6.5%) |
| Dec 2002 | -$53.59M(+132.4%) | -$34.20M(+456.0%) | -$53.59M(+113.9%) |
| Sep 2002 | - | -$6.15M(+25.2%) | -$25.06M(+0.3%) |
| Jun 2002 | - | -$4.91M(-41.1%) | -$24.99M(+12.4%) |
| Mar 2002 | - | -$8.33M(+47.1%) | -$22.24M(-3.6%) |
| Dec 2001 | -$23.07M(+78.9%) | -$5.66M(-7.0%) | -$23.07M(+13.8%) |
| Sep 2001 | - | -$6.09M(+181.5%) | -$20.27M(+27.9%) |
| Jun 2001 | - | -$2.16M(-76.4%) | -$15.85M(-2.2%) |
| Mar 2001 | - | -$9.15M(+219.1%) | -$16.21M(+25.7%) |
| Dec 2000 | -$12.90M(-0.3%) | -$2.87M(+72.4%) | -$12.90M(-2.3%) |
| Sep 2000 | - | -$1.66M(-34.0%) | -$13.21M(-27.3%) |
| Jun 2000 | - | -$2.52M(-56.9%) | -$18.17M(+23.7%) |
| Mar 2000 | - | -$5.84M(+83.8%) | -$14.69M(+13.5%) |
| Dec 1999 | -$12.94M(+60.6%) | -$3.18M(-52.0%) | -$12.94M(+32.6%) |
| Sep 1999 | - | -$6.63M(-790.8%) | -$9.76M(+211.3%) |
| Jun 1999 | - | $959.10K(-123.4%) | -$3.14M(-23.4%) |
| Mar 1999 | - | -$4.09M | -$4.09M |
| Dec 1998 | -$8.06M(+161.1%) | - | - |
| Dec 1997 | -$3.09M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual cash flow from operations?
- What is the all time high annual CFO for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual CFO year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly CFO year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM CFO year-on-year change?
What is BioMarin Pharmaceutical Inc. annual cash flow from operations?
The current annual CFO of BMRN is $572.84M
What is the all time high annual CFO for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual cash flow from operations is $572.84M
What is BioMarin Pharmaceutical Inc. annual CFO year-on-year change?
Over the past year, BMRN annual cash flow from operations has changed by +$413.58M (+259.69%)
What is BioMarin Pharmaceutical Inc. quarterly cash flow from operations?
The current quarterly CFO of BMRN is $185.27M
What is the all time high quarterly CFO for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly cash flow from operations is $221.48M
What is BioMarin Pharmaceutical Inc. quarterly CFO year-on-year change?
Over the past year, BMRN quarterly cash flow from operations has changed by +$66.51M (+56.00%)
What is BioMarin Pharmaceutical Inc. TTM cash flow from operations?
The current TTM CFO of BMRN is $766.77M
What is the all time high TTM CFO for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM cash flow from operations is $766.77M
What is BioMarin Pharmaceutical Inc. TTM CFO year-on-year change?
Over the past year, BMRN TTM cash flow from operations has changed by +$437.91M (+133.16%)